Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. Total Liabilities 2016–2025
Amneal Pharmaceuticals Inc. annual total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Amneal Pharmaceuticals Inc. total liabilities as of December 31, 2025: 3.75B, a 3.83% increase year-over-year.
- Amneal Pharmaceuticals Inc. total liabilities for 2025 were 3.75B, a 3.83% increase from 2024.
- Amneal Pharmaceuticals Inc. total liabilities for 2024 were 3.61B, a 4.57% increase from 2023.
- Amneal Pharmaceuticals Inc. total liabilities for 2023 were 3.45B, a 1.37% decrease from 2022.
- Amneal Pharmaceuticals Inc. total liabilities for 2022 were 3.50B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amneal Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3,749 |
| 2024 | $3,611 |
| 2023 | $3,453 |
| 2022 | $3,501 |
| 2021 | $3,579 |
| 2020 | $3,703 |
| 2019 | $3,434 |
| 2018 | $3,848 |
Amneal Pharmaceuticals Inc. Total Liabilities — FAQ
Amneal Pharmaceuticals Inc. (AMRX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMRX's total liabilities history?
The chart and table above show Amneal Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.